Nicotinic Receptors and Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Schizophrenia
Related studies linked through entity extraction aliases.
Serum Clozapine and Cognition
- Status
- COMPLETED
- Phase
- N/A
Lamictal TM, Haloperidol Decanoate in Schizophrenia
- Status
- TERMINATED
- Phase
- PHASE4
28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years
- Status
- TERMINATED
- Phase
- PHASE4
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.
- Status
- COMPLETED
- Phase
- PHASE1
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
- Status
- COMPLETED
- Phase
- N/A
Effectiveness of Family Group Interventions for People With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE2
The Study of Atypical Antipsychotics-induced Metabolic Disturbances
- Status
- COMPLETED
- Phase
- N/A
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies
- Status
- COMPLETED
- Phase
- N/A
Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning
- Status
- UNKNOWN
- Phase
- PHASE4
Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia
- Status
- COMPLETED
- Phase
- NA
Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine
- Status
- WITHDRAWN
- Phase
- NA
A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls
- Status
- TERMINATED
- Phase
- PHASE4
Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008)
- Status
- COMPLETED
- Phase
- PHASE1
Oculomotor and Spatial Cognition Deficits in Schizophrenia
- Status
- TERMINATED
- Phase
- NA
Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network
- Status
- COMPLETED
- Phase
- PHASE4
Role of Anti-Inflammatory Agents in Patients With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE1
A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.
- Status
- TERMINATED
- Phase
- PHASE1
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families
- Status
- COMPLETED
- Phase
- NA